Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: Long-term results from the International Society of Pediatric Oncology MMT95 study

Journal of Clinical Oncology

Volumn 30, Issue 20, 2012, Pages 2457-2465

  Oberlin, Odile ^a   Rey, Annie ^a   Sanchez De Toledo, José ^d   Martelli, Hél̀ene ^b   Jenney, Meriel E M ^e   Scopinaro, Marcelo ^j   Bergeron, Christophe ^c   Merks, Johannes H M ^k   Bouvet, Nathalie ^a   Ellershaw, Caroline ^f   Kelsey, Anna ^g   Spooner, David ^h   Stevens, Michael C G ⁱ  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

^c CENTRE LÉON BÉRARD   (France)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e CHILDREN S HOSPITAL FOR WALES   (United Kingdom)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^k EMMA CHILDREN S HOSPITAL   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CREATININE; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RELAPSE; CANCER SIZE; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG TREATMENT FAILURE; EVENT FREE SURVIVAL; FEMALE; FEVER; HEMATURIA; HUMAN; INFANT; INFECTION; LEUKOPENIA; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; NEUROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOSARCOMA; SIDE EFFECT; SOFT TISSUE SARCOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUBULAR DYSFUNCTION; UNDIFFERENTIATED SARCOMA; VEIN OCCLUSION; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; MALE; PROGNOSIS; RHABDOMYOSARCOMA; SARCOMA; TREATMENT OUTCOME; VINCRISTINE;

EID: 84864057707     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.3287     Document Type: Article

References (32)

1. Arndt CA, Stoner JA, Hawkins DS, et al: Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group study D9803. J Clin Oncol 27:5182-5188, 2009
2. Raney RB, Walterhouse DO, Meza JL, et al: Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 29:1312-1318, 2011
3. Flamant F, Rodary C, Voute PA, et al: Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the International Society of Pediatric Oncology (SIOP) preliminary results. Radiother Oncol 3:227-236, 1985 (Pubitemid 15112222)
4. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34:1050-1062, 1998 (Pubitemid 28308346)
5. Stevens MC, Rey A, Bouvet N, et al: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: Third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618-2628, 2005 (Pubitemid 46179450)
6. Stevens M, Rey A, Bouvet N, et al: SIOP MMT95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk nonmetastatic rhabdomyosarcoma (RMS). J Clin Oncol 22:802s, 2004 (suppl; abstr 8515)
7. Rodary C, Flamant F, Donaldson SS: An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17:210-215, 1989 (Pubitemid 19187089)
8. Newton WA Jr, Gehan EA, Webber BL, et al: Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification-An Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085, 1995
9. Skinner R, Sharkey IM, Pearson AD, et al: Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol 11:173-190, 1993 (Pubitemid 23059992)
10. Oberlin O, Rey A, Anderson J, et al: Treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment-Results of an international workshop. J Clin Oncol 19:197-204, 2001 (Pubitemid 32063497)
11. Stevens MC: Treatment for childhood rhabdomyosarcoma: The cost of cure. Lancet Oncol 6:77-84, 2005
12. O'Bryan RM, Luce JK, Talley RW, et al: Phase II evaluation of Adriamycin in human neoplasia. Cancer 32:1-8, 1973
13. Pratt CB, Maurer HM, Gieser P, et al: Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A Pediatric Oncology Group study. Med Pediatr Oncol 30:201-209, 1998 (Pubitemid 28082444)
14. Tan C, Etcubanas E, Wollner N, et al: Adriamycin: An antitumor antibiotic in the treatment of neoplastic diseases. Cancer 32:9-17, 1973
15. Bergeron C, Thiesse P, Rey A, et al: Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease. Eur J Cancer 44:427-431, 2008
16. Crist W, Gehan EA, Ragab AH, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995
17. Maurer HM, Beltangady M, Gehan EA, et al: The Intergroup Rhabdomyosarcoma Study-I: A final report. Cancer 61:209-220, 1988 (Pubitemid 18056471)
18. Maurer HM, Gehan EA, Beltangady M, et al: The Intergroup Rhabdomyosarcoma Study-II. Cancer 71:1904-1922, 1993 (Pubitemid 23067412)
19. Womer RB: The Intergroup Rhabdomyosarcoma Studies come of age. Cancer 71:1719-1721, 1993
20. Launchbury AP, Habboubi N: Epirubicin and doxorubicin: A comparison of their characteristics, therapeutic activity and toxicity. Cancer Treat Rev 19:197-228, 1993 (Pubitemid 23238766)
21. Baum ES, Gaynon P, Greenberg L, et al: Phase II trial cisplatin in refractory childhood cancer: Children's Cancer Study Group report. Cancer Treat Rep 65:815-822, 1981 (Pubitemid 11050878)
22. Schmoll H: Review of etoposide single-agent activity. Cancer Treat Rev 9:21-30, 1982 (suppl)
23. Chisholm JC, Machin D, McDowell H, et al: Efficacy of carboplatin given in a phase II window study to children and adolescents with newly diagnosed metastatic soft tissue sarcoma. Eur J Cancer 43:2537-2544, 2007 (Pubitemid 350086935)
24. Pastore G, Peris-Bonet R, Carli M, et al: Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2136-2149, 2006
25. Punyko JA, Mertens AC, Baker KS, et al: Long-term survival probabilities for childhood rhabdomyosarcoma: A population-based evaluation. Cancer 103:1475-1483, 2005 (Pubitemid 40410745)
26. Castex MP, Rubie H, Stevens MC, et al: Extraosseous localized Ewing tumors: Improved outcome with anthracyclines-The French Society of Pediatric Oncology and International Society of Pediatric Oncology. J Clin Oncol 25:1176-1182, 2007 (Pubitemid 46640563)
27. Nesbit ME Jr, Perez CA, Tefft M, et al: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: An intergroup study. Natl Cancer Inst Monogr 56:255-262, 1981 (Pubitemid 12193869)
28. Smith M, Simon R, Cain D, et al: Children and cancer: A perspective from the Cancer Therapy Evaluation Program, National Cancer Institute. Cancer 71:3422-3428, 1993 (Pubitemid 23148537)
29. Bisogno G, De Rossi C, Gamboa Y, et al: Improved survival for children with parameningeal rhabdomyosarcoma: Results from the AIEOP soft tissue sarcoma committee. Pediatr Blood Cancer 50:1154-1158, 2008 (Pubitemid 351555537)
30. Modritz D, Ladenstein R, Pötschger U, et al: Treatment for soft tissue sarcoma in childhood and adolescence: Austrian results within the CWS 96 study. Wien Klin Wochenschr 117:196-209, 2005 (Pubitemid 40645912)
31. Ridola V, Fawaz O, Aubier F, et al: Testicular function of survivors of childhood cancer: A comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer 45:814-818, 2009
32. Oberlin O, Fawaz O, Rey A, et al: Long-term evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 27:5350-5355, 2009